Related Experiment Video

Updated: Jul 15, 2026

Chimeric Antigen Receptor T Cell Manufacturing on an Automated Cell Processor
06:18

Chimeric Antigen Receptor T Cell Manufacturing on an Automated Cell Processor

Published on: August 18, 2023

Advanced Cell Technology, Inc

William M Caldwell1

  • 1Advanced Cell Technology, Inc.

Regenerative Medicine
|May 1, 2007
PubMed

Abstract:

Advanced Cell Technology, Inc. (OTCBB: ACTC) is a biotechnology company applying novel human embryonic stem cell technologies in the emerging field of regenerative medicine. We believe that regenerative medicine has the potential to revolutionize the field by enabling scientists to produce human cells of any kind for use in a wide array of therapies.

More Related Videos

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics
07:48

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics

Published on: September 22, 2011

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

Related Experiment Videos

Last Updated: Jul 15, 2026

Chimeric Antigen Receptor T Cell Manufacturing on an Automated Cell Processor
06:18

Chimeric Antigen Receptor T Cell Manufacturing on an Automated Cell Processor

Published on: August 18, 2023

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics
07:48

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics

Published on: September 22, 2011

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

Related Concept Videos

Cell Lines01:16

Cell Lines

A cell line is a population of cells grown in vitro that can be subcultured over several generations. Normal cells cease to divide after a certain number of cell divisions, a process known as replicative senescence. This number, called the Hayflick limit, was conceptualized by Leonard Hayflick in 1961 when he observed that fetal cells grown in culture could only divide 40-60 times. This limit is due to the shortening of the telomeres during each round of cell division, preventing cell division...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Articles linked to this work by shared authors, journal, and citation graph.

From oncogenesis to approval: the lentiviral gene therapy revolution in Wiskott-Aldrich syndrome.

Regenerative medicine·2026

Extracorporeal shockwave therapy in musculoskeletal conditions: a narrative review.

Regenerative medicine·2026

Clinical manufacturing of adipose-derived stem cells for therapeutic use: current technologies, quality systems and production challenges.

Regenerative medicine·2026

Early economic evaluation of tissue engineered vascular access grafts for hemodialysis.

Regenerative medicine·2026

From targeted drug delivery to tissue regeneration: the evolving role of nanoparticle therapies in liver disease.

Regenerative medicine·2026

Combined umbilical cord-derived mesenchymal stem cell exosome and cell therapy in heart failure with reduced ejection fraction.

Regenerative medicine·2026

[Fundamentals of Therapy for Acute Ischemic Stroke:Basic Knowledge for the Practical Assessment of Eligibility].

No shinkei geka. Neurological surgery·2026

[History and Clinical Significance of Perfusion Imaging in Acute Ischemic Stroke:From the Penumbra Concept to Tissue-Based Patient Selection].

No shinkei geka. Neurological surgery·2026

From Mesenchymal Roots to Pluripotent Reprogramming: Exosomal Crossroads in Regenerative Medicine.

SLAS technology·2026

Intervention Strategies of Nonanastomotic Biliary Strictures: From Mechanical Repair to Biological Reconstruction.

Journal of clinical and experimental hepatology·2026

Machine learning-derived R-loop-related diagnostic signature for psoriasis: a multi-cohort and single-cell validation study.

Frontiers in immunology·2026

Rapid Clearance of microRNA-371a-3p: A Longitudinal Study of Serum Levels in Patients with Localized Testicular Germ Cell Tumors.

European urology open science·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us